These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21498445)

  • 1. Vaccination against bluetongue: new rules in the pipeline.
    Vet Rec; 2011 Apr; 168(15):393. PubMed ID: 21498445
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Detection of bluetongue virus genome after vaccination with an inactivated vaccine.
    Eschbaumer M; Wäckerlin R; Hoffmann B; Beer M
    Vaccine; 2010 Jan; 28(4):881-2. PubMed ID: 19925907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination against bluetongue serotype 8 in the Netherlands].
    Kuijk H; Jansen M; Moulin V; Makoschey B
    Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats.
    Bréard E; Belbis G; Hamers C; Moulin V; Lilin T; Moreau F; Millemann Y; Montange C; Sailleau C; Durand B; Desprat A; Viarouge C; Hoffmann B; de Smit H; Goutebroze S; Hudelet P; Zientara S
    Vaccine; 2011 Mar; 29(13):2495-502. PubMed ID: 21256877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bluetongue vaccination in Europe.
    Zientara S; MacLachlan NJ; Calistri P; Sanchez-Vizcaino JM; Savini G
    Expert Rev Vaccines; 2010 Sep; 9(9):989-91. PubMed ID: 20822340
    [No Abstract]   [Full Text] [Related]  

  • 6. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against bluetongue.
    Vet Rec; 2012 Jan; 170(1):16. PubMed ID: 22228865
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines.
    González JM; Figueras L; Ortega ME; Lozano M; de Arcaute MR; Royo R; Cebrián LM; Ferrer LM; Fariñas F; de Jalón JA; De las Heras M
    Vet Rec; 2010 Jun; 166(24):757-8. PubMed ID: 20543167
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
    van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Vrijenhoek MP; Debyser I; Gregg DA; Dufe DM; Moulin V; Moormann RJ; de Smit AJ
    Vaccine; 2012 Jan; 30(3):647-55. PubMed ID: 22107846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bluetongue vaccines.
    Noad R; Roy P
    Vaccine; 2009 Nov; 27 Suppl 4():D86-9. PubMed ID: 19837295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bluetongue vaccines: the past, present and future.
    Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
    Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
    Steinrigl A; Revilla-Fernández S; Eichinger M; Koefer J; Winter P
    Vaccine; 2010 Aug; 28(34):5573-81. PubMed ID: 20600511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [To vaccinate against bluetongue or not?].
    Backer J
    Tijdschr Diergeneeskd; 2009 Apr; 134(8):348-9. PubMed ID: 19462622
    [No Abstract]   [Full Text] [Related]  

  • 18. [A lot of interest in blue tongue vaccination].
    Haneveld JK
    Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):622-3. PubMed ID: 18767305
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.
    Gethmann J; Hüttner K; Heyne H; Probst C; Ziller M; Beer M; Hoffmann B; Mettenleiter TC; Conraths FJ
    Vaccine; 2009 Jun; 27(31):4118-26. PubMed ID: 19410620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.